RELEXXII
NDC 68025-084, methylphenidate hydrochloride, tablet, extended release, from Vertical Pharmaceuticals, LLC.
- Product NDC
- 68025-084
- Status
- Listed
- Labeler
- Vertical Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216117
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/68025-084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE72 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68025-084-30 | 68025008430 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68025-084-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/22d5fa47-b5b9-4fd9-980c-4eb88e95ae5dNADAC price for package 68025008430
GET /v1/drugs/nadac/68025008430
Use it
Look up 68025-084 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68025-084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68025-084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.